PHI with Ureteral stones
How does this condition affect your private health insurance?
Ureteral stones are hard deposits of minerals and salts that form in kidneys and travel into the ureters, tubes connecting to the bladder. They cause severe renal colic, intense flank pain radiating to the groin. Formation links to dehydration, diet, genetics, and conditions like hyperparathyroidism. Symptoms include excruciating pain, hematuria, nausea, vomiting, and frequent urination. Untreated, they can cause urinary obstruction, leading to hydronephrosis, infection, or kidney damage. Treatment varies by stone size and location, from pain management and hydration for small stones to medical expulsive therapy, lithotripsy, or surgical removal for larger or obstructing ones.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 15%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically a few hours to several days until the stone passes or is treated.
Duration of Illness (Lifetime)
Often a one-time event, but recurrence rates are significant (e.g., 50% within 5-10 years) without preventative measures, making it a recurrent disease for many.
Cost of Treatment (Initial)
Ranges from several hundreds to tens of thousands of dollars, depending on diagnostic imaging, emergency care, and necessary interventions like lithotripsy or ureteroscopy.
Cost of Treatment (Lifetime)
Potentially hundreds of thousands of dollars for individuals with recurrent stones requiring multiple interventions and long-term management.
Mortality Rate
Very low (<0.1%), mainly associated with severe complications like urosepsis in obstructed kidneys.
Risk of Secondary Damages
Moderate (10-25%) for complications like kidney damage (hydronephrosis), impaired kidney function, or infection (pyelonephritis, urosepsis) if untreated or in complicated cases.
Probability of Full Recovery
High (90-95%) with timely and appropriate medical or surgical intervention, most individuals recover without long-term consequences.
Underlying Disease Risk
Moderate (20-40%) for underlying metabolic disorders (e.g., hypercalciuria, hyperoxaluria, gout) or a higher propensity for urinary tract infections.